ArticleCancers2021

Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters.

Sol-Bi Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.